Follow the people · Insider
Linda Burkly
Linda Burkly files insider transactions with the SEC as an evp, chief scientific officer of Editas Medicine (EDIT). We hold 4 disclosed purchases and sales filed since 25 July 2023, 2 of them in the last 90 days.
- Files forEDIT
- Disclosed buys and sells4 in all, 2 in the last 90 days
- Last disclosure4 September 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 24 July 2023 — 3 September 2026EVP, Chief Scientific Officer · Editas Medicine (EDIT)20 Form 4 lines · source: SEC Form 4
Everything they disclosed
20 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 709 shares of Editas MedicineSEC Form 44 September 2026Common Stock · traded 3 September 2026 · filed 4 September 2026
- ▼ sold on the open market 4,928 shares of Editas MedicineSEC Form 429 July 2026Common Stock · traded 28 July 2026 · filed 29 July 2026
- ▼ sold on the open market 731 shares of Editas MedicineSEC Form 45 June 2026Common Stock · traded 3 June 2026 · filed 5 June 2026
- was granted 292,856 shares of Editas Medicine (a derivative holding)SEC Form 416 March 2026Stock Option (right to buy) · traded 12 March 2026 · filed 16 March 2026
- was granted 292,856 shares of Editas Medicine (a derivative holding)SEC Form 416 March 2026Stock Option (right to buy) · traded 12 March 2026 · filed 16 March 2026
- ▼ sold on the open market 749 shares of Editas MedicineSEC Form 44 March 2026Common Stock · traded 3 March 2026 · filed 4 March 2026
- ▼ sold on the open market 749 shares of Editas MedicineSEC Form 44 March 2026Common Stock · traded 3 March 2026 · filed 4 March 2026
- ▼ sold on the open market 713 shares of Editas MedicineSEC Form 44 December 2025Common Stock · traded 3 December 2025 · filed 4 December 2025
- ▼ sold on the open market 710 shares of Editas MedicineSEC Form 44 September 2025Common Stock · traded 3 September 2025 · filed 4 September 2025
- ▼ sold on the open market 5,121 shares of Editas MedicineSEC Form 44 August 2025Common Stock · traded 31 July 2025 · filed 4 August 2025
- ▼ sold on the open market 726 shares of Editas MedicineSEC Form 44 June 2025Common Stock · traded 3 June 2025 · filed 4 June 2025
- was granted 275,100 shares of Editas Medicine (a derivative holding)SEC Form 427 March 2025Stock Option (right to buy) · traded 8 March 2025 · filed 27 March 2025
- was granted 70,000 shares of Editas Medicine (a derivative holding)SEC Form 427 March 2025Stock Option (right to buy) · traded 8 March 2025 · filed 27 March 2025
- ▼ sold on the open market 2,891 shares of Editas MedicineSEC Form 45 March 2025Common Stock · traded 4 March 2025 · filed 5 March 2025
- ▼ sold on the open market 11,886 shares of Editas MedicineSEC Form 426 July 2024Common Stock · traded 25 July 2024 · filed 26 July 2024
- was granted 74,400 shares of Editas Medicine (a derivative holding)SEC Form 45 March 2024Stock Option (right to buy) · traded 2 March 2024 · filed 5 March 2024
- was granted 24,800 shares of Editas MedicineSEC Form 45 March 2024Common Stock · traded 2 March 2024 · filed 5 March 2024
- was granted 15,055 shares of Editas MedicineSEC Form 45 March 2024Common Stock · traded 2 March 2024 · filed 5 March 2024
- was granted 135,500 shares of Editas Medicine (a derivative holding)SEC Form 425 July 2023Stock Option (right to buy) · traded 24 July 2023 · filed 25 July 2023
- was granted 45,167 shares of Editas MedicineSEC Form 425 July 2023Common Stock · traded 24 July 2023 · filed 25 July 2023
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.